IVVD CIK: 1832038

Invivyd, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−185
FY22:
−220
FY23:
−173
FY24:
−170
FY25:
−58.1
Change from FY21 to FY25
millions USD
FY21:
−50.7
FY22:
−231
FY23:
281
FY24:
−0.14
FY25:
−0.16
Change from FY21 to FY25
millions USD
FY21:
663
FY22:
0.51
FY23:
1.05
FY24:
39.3
FY25:
216
millions USD
FY21:
427
FY22:
−450
FY23:
109
FY24:
−131
FY25:
157
(positive)
Change from FY21 to FY25
millions USD
FY21:
−185
FY22:
−222
FY23:
−174
FY24:
−171
FY25:
−58.3

All amounts in millions USD Data source:SEC EDGAR